Fig. 1: Kaplan-Meier Curves for Progression-Free Survival (PFS) and Overall Survival (OS) in the Study Cohort.
From: Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study

A PFS; (B) OS.
From: Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study

A PFS; (B) OS.